Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022

BUY
$66.18 - $83.18 $5,691 - $7,153
86 Added 9.91%
954 $72,000
Q1 2022

May 02, 2022

SELL
$66.02 - $79.71 $38,027 - $45,912
-576 Reduced 39.89%
868 $69,000
Q4 2021

Feb 02, 2022

BUY
$63.34 - $74.11 $91,462 - $107,014
1,444 New
1,444 $107,000
Q2 2021

Aug 04, 2021

SELL
$79.87 - $87.53 $35,142 - $38,513
-440 Closed
0 $0
Q1 2021

May 04, 2021

BUY
$76.02 - $100.5 $31,168 - $41,205
410 Added 1366.67%
440 $36,000
Q4 2020

Feb 08, 2021

BUY
$80.74 - $97.7 $2,422 - $2,931
30 New
30 $3,000
Q2 2020

Aug 11, 2020

SELL
$74.18 - $108.93 $87,087 - $127,883
-1,174 Closed
0 $0
Q1 2020

May 12, 2020

BUY
$63.18 - $85.97 $74,173 - $100,928
1,174 New
1,174 $86,000
Q4 2018

Feb 13, 2019

SELL
$58.5 - $69.94 $73,651 - $88,054
-1,259 Closed
0 $0
Q3 2018

Nov 08, 2018

BUY
$61.75 - $74.23 $46,065 - $55,375
746 Added 145.42%
1,259 $87,000
Q2 2018

Aug 01, 2018

BUY
$60.85 - $83.98 $30,242 - $41,738
497 Added 3106.25%
513 $34,000
Q1 2018

May 02, 2018

BUY
$83.06 - $100.98 $1,328 - $1,615
16 New
16 $1,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.1B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Migdal Insurance & Financial Holdings Ltd. Portfolio

Follow Migdal Insurance & Financial Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Migdal Insurance & Financial Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Migdal Insurance & Financial Holdings Ltd. with notifications on news.